UK phase IV, observational study to assess quality of life in patients (pts) with pancreatic neuroendocrine tumours (pNETS) receiving treatment with everolimus: the “real-world” OBLIQUE study.
Authors
Ramage, JPunia, P
Faluyi, O
Frilling, A
Meyer, T
Kapur, G
Cave, J
Wadsley, J
Cummins, S
Farrugia, D
Starling, N
Wall, L
Saharan, R
Valle, Juan W
Affiliation
Institute of Liver Studies, King’s College Hospital, LondonIssue Date
2016-10-01
Metadata
Show full item recordCitation
UK phase IV, observational study to assess quality of life in patients (pts) with pancreatic neuroendocrine tumours (pNETS) receiving treatment with everolimus: the “real-world” OBLIQUE study. 2016, 27(suppl_6):437P Annals of OncologyJournal
Annals of OncologyDOI
10.1093/annonc/mdw369.22Additional Links
https://academic.oup.com/annonc/article/2799176/UKType
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdw369.22